GALLIMUNE 303 ND+IB+ART
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
06-12-2016
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
INACTIVATED NEWCASTLE DISEASE VIRUS, ULSTER 2C STRAIN, INACTIVATED INFECTIOUS BRONCHITIS VIRUS, MASS41 STRAIN, INACTIVATED AVIAN RHINOTRACHEITIS VIRUS (SWOLLEN HEAD SYNDROME), VCO3 STRAIN
थमां उपलब्ध:
Merial Animal Health Limited
ए.टी.सी कोड:
QI01AA21
INN (इंटरनेशनल नाम):
INACTIVATED NEWCASTLE DISEASE VIRUS, ULSTER 2C STRAIN, INACTIVATED INFECTIOUS BRONCHITIS VIRUS, MASS41 STRAIN, INACTIVATED AVIAN
डोज़:
Per Cent
फार्मास्यूटिकल फॉर्म:
Emulsion for Injection
प्रिस्क्रिप्शन प्रकार:
POM
चिकित्सीय समूह:
Fowl - Chicken
चिकित्सीय क्षेत्र:
Avian infectious bronchitis virus vaccine + Newcastle disease virus / paramyxovirus vaccine + Avian
चिकित्सीय संकेत:
Immunological - Inactivated vaccine
प्राधिकरण का दर्जा:
Authorised
प्राधिकरण की तारीख:
2005-11-25
उत्पाद विशेषताएं
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
GALLIMUNE 303 ND+IB+ART
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Water-in oil emulsion for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens (breeder and layer pullets).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Booster immunisation of breeder and layer pullets after vaccination with live vaccines against:
-
Newcastle Disease virus in order to reduce egg drop linked to Newcastle Disease infection,
-
Infectious Bronchitis virus in order to reduce egg drop linked to Infectious Bronchitis infection caused by the Mass41 strain,
-
Avian pneumovirus in order to reduce respiratory signs linked to avian pneumovirus infection (Avian Rhinotracheitis).
Newcastle Disease and Infectious Bronchitis components:
-
onset of immunity: 4 weeks after vaccination,
-
duration of immunity: one laying period.
Avian Rhinotracheitis component:
Immunity has been demonstrated by challenge 14 weeks after vaccination and persists until the end of the laying period.
4.3 CONTRAINDICATIONS
None
Each 0.3-ml dose of vaccine contains:
ACTIVE SUBSTANCE(S):
Inactivated Newcastle Disease virus, Ulster 2C strain, at least
50PD
50
1
Inactivated Infectious Bronchitis virus, Mass41 strain, at least
18 HI.U
Inactivated Avian Rhinotracheitis virus (Swollen Head Syndrome), VCO3 strain, at least
60 IP.U
The concentrations are expressed by the antibody titre obtained during the potency test. One unit
(U) corresponding to an antibody titre of 1.
HI: haemagglutination inhibiting - IP: interference percentage
(1): Minimum protective dose according to monograph 0870 of Ph. Eur.
ADJUVANT(S):
Paraffin oil
170 to 186 mg
EXCIPIENT(S):
Thiomersal, at most
30 µg
Formaldehyde, at most
45 µg
For a full list of excipients, see sectio
पूरा दस्तावेज़ पढ़ें
